North London teaching hospital that is a European Centre of Excellence for neuroendocrine tumours, where Martyn Caplin led the CLARINET trial of lanreotide.
The Royal Free Hospital in Hampstead is the main site of the Royal Free London NHS Foundation Trust and a teaching hospital of University College London. Its Neuroendocrine Tumour Unit, led by Martyn Caplin, is an ENETS Centre of Excellence and coordinated CLARINET, the 2014 New England Journal of Medicine trial in which lanreotide lengthened progression-free survival in non-functioning enteropancreatic neuroendocrine tumours. The hospital is also a national centre for liver transplantation and hepatobiliary cancer.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Royal Free London NHS Foundation Trust, including child institutions. 360 works · 3,371 citations · 71% open access · 8% clinical trials · 4% reviews.
Shares AMMF, the Cholangiocarcinoma Charity, Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer.
Shares Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
Shares Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
Shares Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.